pLVX-DsRed-Express2-N1载体

pLVX-DsRed-Express2-N1载体

收藏
  • ¥1500
  • ZKbscience
  • ZK-0020700
  • 中国/美国
  • 2025年11月21日
    avatar
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 技术资料
    • 库存

      60

    • 英文名

      pLVX-DsRed-Express2-N1

    • 保质期

      三年

    • 供应商

      再康生物

    • 保存条件

      常温

    • 规格

      5ug质粒

    pLVX-DsRed-Express2-N1载体

    基本信息

    质粒类型: 慢病毒载体
    高拷贝/低拷贝: 高拷贝
    启动子: CMV
    克隆方法: 多克隆位点,限制性内切酶
    载体大小: 8745 bp (查看载体序列)
    5' 测序引物及序列: CMV-F: CGCAAATGGGCGGTAGGCGTG(Invitrogen)
    载体标签: C-DsRed
    载体抗性: Ampicillin (氨苄 青 霉 素)
    筛选标记: Puromycin (嘌呤霉素)
    备注: 包含有Tet-On 3G反式激活蛋白,多西环素(dozkcycline)诱导基因表达的慢病毒载体,C端含有DsRED荧光蛋白标签。

    订购信息

    产品编号 产品名称 规格 价格
    ZK2019 pLVX-DsRed-Express2-N1

    5ug质粒

    ¥1500.00

    质粒图谱

    载体描述

    pLVX-DsRed-Express2-N1 is an HIV-1-based, lentiviral expression vector that allows you to express your gene of interest fused to DsRed-Express2, a mutant fluorescent protein derived from the tetrameric Discosoma sp. red fluorescent protein, DsRed (1). Genes cloned into the multiple cloning site (MCS), located upstream of the DsRed-Express2 coding sequence, are expressed as N-terminal DsRed-Express2 fusion proteins. Expression of the fusion protein is driven by the constitutively active human cytomegalovirus immediate early promoter (PCMV IE), located just upstream of the MCS. Lentiviral particles derived from the vector allow the expression of DsRed-Express2 fusion proteins in virtually any cell type, including primary cells. The unmodified vector expresses DsRed-Express2, and may be used to produce marker virus to optimize infection protocols.

    pLVX-DsRed-Express2-N1 contains all of the viral processing elements necessary for the production of replication-incompetent lentivirus, as well as elements to improve viral titer, transgene expression, and overall vector function. The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) promotes RNA processing events and enhances nuclear export of viral and transgene RNA (2), leading to increased viral titers from packaging cells, and enhanced expression of your gene of interest in target cells. In addition, the vector includes a Rev-response element (RRE), which further increases viral titers by enhancing the transport of unspliced viral RNA out of the nucleus (3). Finally, pLVX-DsRed-Express2-N1 also contains a central polypurine tract/central termination sequence element (cPPT/CTS). During target cell infection, this element creates a central DNA flap that increases nuclear import of the viral genome, resulting in improved vector integration and more efficient transduction (4).

    In addition to lentiviral elements, pLVX-DsRed-Express2-N1 contains a puromycin resistance gene (Puror ) under the control of the murine phosphoglycerate kinase (PGK) promoter (PPGK) for the selection of stable transductants. The vector also contains a pUC origin of replication and an E. coli ampicillin resistance gene (Ampr ) for propagation and selection in bacteria.

    载体应用

    To construct a fusion protein, the gene of interest must be cloned into pLVX-DsRed-Express2-N1 so that it is in-frame with the DsRed-Express2 coding sequence. The inserted sequence should include an initiation codon (ATG) and lack in-frame stop codons.

    The fusion protein is constitutively expressed when pLVX-DsRed-Express2-N1 is transduced into target cells. Before the vector can be transduced, however, it must be transfected into 293T packaging cells with our Lenti-X™ HT Packaging System (Cat. Nos. 632160 and 632161). This packaging system allows you to safely produce high titer, infectious, replication-incompetent, VSV-G pseudotyped lentiviral particles that can infect a wide range of cell types, including non-dividing and primary cells (5).

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2000
    上海泽叶生物科技有限公司
    2025年07月11日询价
    ¥1500
    上海信裕生物科技有限公司
    2025年07月07日询价
    ¥750
    上海盖宁生物科技有限公司
    2025年12月12日询价
    ¥800
    上海沪震实业有限公司
    2025年07月14日询价
    ¥1000
    上海再康生物科技有限公司
    2025年11月21日询价
    pLVX-DsRed-Express2-N1载体
    ¥1500